The Evening Standard

US sinks another $2.1 billion into a potential vaccine

July 31, 2020

Pharma giants GlaxoSmithKline and Sanofi Pasteur have announced they will supply 100 million doses of its experimental COVID-19 vaccine to the United States as governments buy up supplies in hopes something will work.

 

The United States will pay up to $2.1 billion "for development including clinical trials, manufacturing, scale-up and delivery of its vaccine," the companies said. Sanofi will get the bulk of the funds.

 

The US government has a further option for the supply of an additional 500 million doses longer term as part of its Operation Warp Speed program.

Play this podcast on Podbean App